WEITIAN GROUP LLC. Mediaroom - PR Newswire APAC

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"...

2023-01-31 20:30 970

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

SHANGHAI, Jan. 19, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"...

2023-01-19 20:30 1638

Addentax Group Corp. Announces Entry of a Securities Purchase Agreement

SHENZHEN, China, Jan. 4, 2023 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (N...

2023-01-04 22:52 1399

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

SHANGHAI, Dec. 5, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company")...

2022-12-05 20:30 1135

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

SHANGHAI, Nov. 3, 2022 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"),...

2022-11-03 19:30 1169

Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications

SHANGHAI, Sept. 28, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company...

2022-09-28 21:18 986

Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Closing of $25 Million Public Offering of Common Stock

SHENZHEN, China, Sept. 2, 2022 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (...

2022-09-02 22:51 8595

Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management

SHANGHAI, Sept 1, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company")...

2022-09-01 19:30 2282

Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock

SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (...

2022-08-31 04:40 1784

MDJM Acquires Fernie Castle Hotel to Initiate the Expansion Strategy to European Market

TIANJIN, China, Aug. 23, 2022 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an...

2022-08-23 19:30 1754

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course

SHANGHAI, June 13, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"...

2022-06-13 18:30 1256

Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results

SHANGHAI, May 9, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"),...

2022-05-09 18:30 1933

Hanjiao Group Invited by Rising China Interview Show

BEIJING, Dec. 21, 2021 /PRNewswire/ -- Hanjiao Group, Inc. ("Hanjiao" or the "Company") (OTC Pink: ...

2021-12-21 20:30 2989

Hanjiao Group Received Enterprise Credit Certifications

BEIJING, Nov. 30, 2021 /PRNewswire/ -- Hanjiao Group, Inc. ("Hanjiao" or the "Company") (OTC Pink:...

2021-11-30 20:30 1598

Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment

SHANGHAI, Oct. 29, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Compan...

2021-10-29 18:30 1232

Latest News